Free Dengue - Sustainable Large Scale Vaccine Delivery in Low-Income Markets (A): The Challenges of Vaccine Launches in Emerging Markets Case Study Solution | Assignment Help

Harvard Case - Dengue - Sustainable Large Scale Vaccine Delivery in Low-Income Markets (A): The Challenges of Vaccine Launches in Emerging Markets

"Dengue - Sustainable Large Scale Vaccine Delivery in Low-Income Markets (A): The Challenges of Vaccine Launches in Emerging Markets" Harvard business case study is written by Philip Parker, Pierfitte Marion. It deals with the challenges in the field of Entrepreneurship. The case study is 3 page(s) long and it was first published on : Jan 25, 2016

At Fern Fort University, we recommend a multi-pronged approach for Sanofi Pasteur to successfully launch its dengue vaccine in low-income markets. This approach leverages entrepreneurship, innovation, and strategic partnerships to address the unique challenges of these markets. The strategy focuses on building a sustainable, scalable, and impactful vaccine delivery model that prioritizes access, affordability, and community engagement.

2. Background

This case study focuses on Sanofi Pasteur, a leading vaccine manufacturer, facing the challenge of launching its dengue vaccine in low-income markets. The company faces several hurdles, including:

  • Limited access to healthcare: Many low-income countries lack robust healthcare infrastructure, making it difficult to reach target populations.
  • Financial constraints: Affordability is a major concern, as many individuals in these markets cannot afford the vaccine.
  • Complex logistics: Distributing vaccines effectively in remote and underserved areas requires robust supply chain management.
  • Public perception: Building trust and overcoming vaccine hesitancy is crucial for successful adoption.

The key protagonists are Sanofi Pasteur?s leadership team, tasked with developing a strategy for launching the vaccine in these challenging markets.

3. Analysis of the Case Study

To analyze the case, we can utilize the Porter?s Five Forces Framework:

  • Threat of New Entrants: The threat of new entrants is moderate. While developing a dengue vaccine is complex, new players could enter the market with innovative delivery models or lower pricing strategies.
  • Bargaining Power of Buyers: The bargaining power of buyers is high. Low-income markets are price-sensitive, and governments and NGOs have significant influence on vaccine procurement.
  • Bargaining Power of Suppliers: The bargaining power of suppliers is moderate. Sanofi Pasteur relies on raw materials and manufacturing capabilities, but there is potential for alternative suppliers or partnerships.
  • Threat of Substitutes: The threat of substitutes is low. Dengue vaccines are currently the most effective preventive measure against the disease.
  • Competitive Rivalry: Competitive rivalry is moderate. Sanofi Pasteur faces competition from other vaccine manufacturers, but the market is still developing.

Further Analysis:

  • Market Segmentation: Sanofi Pasteur needs to identify key segments within the low-income market, considering factors like age, geographic location, and access to healthcare.
  • Value Proposition: The company must clearly define the value proposition for each segment, highlighting the benefits of vaccination and addressing concerns around cost and accessibility.
  • Distribution Strategy: Sanofi Pasteur needs to develop a multi-channel distribution strategy that leverages existing healthcare infrastructure, community health workers, and mobile clinics.
  • Marketing and Communication: Effective communication strategies are crucial to building trust and overcoming vaccine hesitancy. Engaging local communities and leveraging trusted messengers is key.

4. Recommendations

1. Leverage Partnerships:

  • Government Agencies: Collaborate with national and local governments to integrate the dengue vaccine into existing immunization programs. This can provide access to infrastructure, funding, and expertise.
  • Non-Governmental Organizations (NGOs): Partner with NGOs working in the health sector to reach remote communities and provide education and outreach programs.
  • Local Businesses: Engage local businesses, such as pharmacies and clinics, to distribute the vaccine and provide services.
  • Pharmaceutical Distributors: Partner with established pharmaceutical distributors to ensure efficient and reliable supply chain management.

2. Innovation in Delivery:

  • Mobile Clinics: Deploy mobile clinics to reach underserved populations in remote areas. This model can offer vaccination services, education, and health screenings.
  • Community Health Workers: Train and empower community health workers to deliver vaccines and provide health education within their communities.
  • Digital Platforms: Develop mobile applications and online platforms to provide information, schedule appointments, and track vaccination records.

3. Pricing and Affordability:

  • Tiered Pricing: Offer tiered pricing models based on income levels or government subsidies to make the vaccine accessible to a wider range of individuals.
  • Public-Private Partnerships: Work with governments and NGOs to secure funding for vaccine subsidies or programs.
  • Microfinance Options: Explore microfinance options to help individuals finance the cost of vaccination.

4. Building Trust and Engagement:

  • Community Engagement: Conduct community meetings and workshops to address concerns and build trust around the dengue vaccine.
  • Local Influencers: Partner with local leaders, religious figures, and community health workers to promote vaccination.
  • Social Media Campaigns: Utilize social media platforms to raise awareness about dengue and the benefits of vaccination.

5. Sustainable Business Model:

  • Social Impact Investment: Seek investment from impact investors who prioritize social and environmental returns alongside financial returns.
  • Pay-for-Performance Models: Explore pay-for-performance models where funding is contingent on achieving vaccination targets and reducing dengue cases.
  • Cost-Effectiveness Analysis: Conduct cost-effectiveness analyses to demonstrate the long-term benefits of vaccination and justify investment.

5. Basis of Recommendations

These recommendations are based on the following considerations:

  • Core Competencies: Leveraging Sanofi Pasteur?s expertise in vaccine development and manufacturing while partnering with local organizations to address specific market needs.
  • External Customers: Meeting the needs of diverse populations within low-income markets by offering affordable, accessible, and culturally sensitive solutions.
  • Competitors: Staying ahead of the competition by developing innovative delivery models and building strong partnerships.
  • Attractiveness: The recommendations are expected to improve access to the dengue vaccine, reduce disease burden, and generate positive social and financial returns.

6. Conclusion

Sanofi Pasteur can successfully launch its dengue vaccine in low-income markets by adopting a multi-faceted approach that combines entrepreneurship, innovation, and strategic partnerships. This strategy prioritizes access, affordability, and community engagement, ensuring a sustainable and impactful vaccine delivery model. By embracing these recommendations, Sanofi Pasteur can contribute to improving public health and achieving its business objectives in these challenging markets.

7. Discussion

Alternatives:

  • Focusing solely on government procurement: This approach could limit reach and potentially exclude vulnerable populations.
  • Adopting a purely commercial model: This could result in high prices and limited access for low-income individuals.

Risks and Key Assumptions:

  • Political Instability: Political instability in some countries could disrupt vaccine distribution and program implementation.
  • Vaccine Hesitancy: Overcoming vaccine hesitancy requires robust communication strategies and community engagement.
  • Funding Challenges: Securing sufficient funding for vaccine subsidies and program implementation is crucial.

8. Next Steps

  • Develop a comprehensive business plan: Outline the strategy, target markets, partnerships, and financial projections.
  • Pilot program implementation: Launch pilot programs in selected markets to test and refine the approach.
  • Build a strong team: Assemble a team with expertise in vaccine delivery, public health, and market development.
  • Monitor and evaluate: Continuously monitor and evaluate program performance to identify areas for improvement and ensure sustainability.

By taking these steps, Sanofi Pasteur can successfully navigate the challenges of launching its dengue vaccine in low-income markets and contribute to improving public health in these regions.

Hire an expert to write custom solution for HBR Entrepreneurhsip case study - Dengue - Sustainable Large Scale Vaccine Delivery in Low-Income Markets (A): The Challenges of Vaccine Launches in Emerging Markets

more similar case solutions ...

Case Description

This case explores the difficulties involved in commercialising vaccines in low-income settings. The focus is the dengue vaccine, launched at the end of 2015, which was first commercialised in emerging markets. It considers issues of affordability and distribution, higlighting the need for business model innovation in all industries.

🎓 Struggling with term papers, essays, or Harvard case studies? Look no further! Fern Fort University offers top-quality, custom-written solutions tailored to your needs. Boost your grades and save time with expertly crafted content. Order now and experience academic excellence! 🌟📚 #MBA #HarvardCaseStudies #CustomEssays #AcademicSuccess #StudySmart Write my custom case study solution for Harvard HBR case - Dengue - Sustainable Large Scale Vaccine Delivery in Low-Income Markets (A): The Challenges of Vaccine Launches in Emerging Markets

Hire an expert to write custom solution for HBR Entrepreneurhsip case study - Dengue - Sustainable Large Scale Vaccine Delivery in Low-Income Markets (A): The Challenges of Vaccine Launches in Emerging Markets

Dengue - Sustainable Large Scale Vaccine Delivery in Low-Income Markets (A): The Challenges of Vaccine Launches in Emerging Markets FAQ

What are the qualifications of the writers handling the "Dengue - Sustainable Large Scale Vaccine Delivery in Low-Income Markets (A): The Challenges of Vaccine Launches in Emerging Markets" case study?

Our writers hold advanced degrees in their respective fields, including MBAs and PhDs from top universities. They have extensive experience in writing and analyzing complex case studies such as " Dengue - Sustainable Large Scale Vaccine Delivery in Low-Income Markets (A): The Challenges of Vaccine Launches in Emerging Markets ", ensuring high-quality, academically rigorous solutions.

How do you ensure confidentiality and security in handling client information?

We prioritize confidentiality by using secure data encryption, access controls, and strict privacy policies. Apart from an email, we don't collect any information from the client. So there is almost zero risk of breach at our end. Our financial transactions are done by Paypal on their website so all your information is very secure.

What is Fern Fort Univeristy's process for quality control and proofreading in case study solutions?

The Dengue - Sustainable Large Scale Vaccine Delivery in Low-Income Markets (A): The Challenges of Vaccine Launches in Emerging Markets case study solution undergoes a rigorous quality control process, including multiple rounds of proofreading and editing by experts. We ensure that the content is accurate, well-structured, and free from errors before delivery.

Where can I find free case studies solution for Harvard HBR Strategy Case Studies?

At Fern Fort University provides free case studies solutions for a variety of Harvard HBR case studies. The free solutions are written to build "Wikipedia of case studies on internet". Custom solution services are written based on specific requirements. If free solution helps you with your task then feel free to donate a cup of coffee.

I’m looking for Harvard Business Case Studies Solution for Dengue - Sustainable Large Scale Vaccine Delivery in Low-Income Markets (A): The Challenges of Vaccine Launches in Emerging Markets. Where can I get it?

You can find the case study solution of the HBR case study "Dengue - Sustainable Large Scale Vaccine Delivery in Low-Income Markets (A): The Challenges of Vaccine Launches in Emerging Markets" at Fern Fort University.

Can I Buy Case Study Solution for Dengue - Sustainable Large Scale Vaccine Delivery in Low-Income Markets (A): The Challenges of Vaccine Launches in Emerging Markets & Seek Case Study Help at Fern Fort University?

Yes, you can order your custom case study solution for the Harvard business case - "Dengue - Sustainable Large Scale Vaccine Delivery in Low-Income Markets (A): The Challenges of Vaccine Launches in Emerging Markets" at Fern Fort University. You can get a comprehensive solution tailored to your requirements.

Can I hire someone only to analyze my Dengue - Sustainable Large Scale Vaccine Delivery in Low-Income Markets (A): The Challenges of Vaccine Launches in Emerging Markets solution? I have written it, and I want an expert to go through it.

🎓 Struggling with term papers, essays, or Harvard case studies? Look no further! Fern Fort University offers top-quality, custom-written solutions tailored to your needs. Boost your grades and save time with expertly crafted content. Order now and experience academic excellence! 🌟📚 #MBA #HarvardCaseStudies #CustomEssays #AcademicSuccess #StudySmart Pay an expert to write my HBR study solution for the case study - Dengue - Sustainable Large Scale Vaccine Delivery in Low-Income Markets (A): The Challenges of Vaccine Launches in Emerging Markets

Where can I find a case analysis for Harvard Business School or HBR Cases?

You can find the case study solution of the HBR case study "Dengue - Sustainable Large Scale Vaccine Delivery in Low-Income Markets (A): The Challenges of Vaccine Launches in Emerging Markets" at Fern Fort University.

Which are some of the all-time best Harvard Review Case Studies?

Some of our all time favorite case studies are -

Can I Pay Someone To Solve My Case Study - "Dengue - Sustainable Large Scale Vaccine Delivery in Low-Income Markets (A): The Challenges of Vaccine Launches in Emerging Markets"?

Yes, you can pay experts at Fern Fort University to write a custom case study solution that meets all your professional and academic needs.

Do I have to upload case material for the case study Dengue - Sustainable Large Scale Vaccine Delivery in Low-Income Markets (A): The Challenges of Vaccine Launches in Emerging Markets to buy a custom case study solution?

We recommend to upload your case study because Harvard HBR case studies are updated regularly. So for custom solutions it helps to refer to the same document. The uploading of specific case materials for Dengue - Sustainable Large Scale Vaccine Delivery in Low-Income Markets (A): The Challenges of Vaccine Launches in Emerging Markets ensures that the custom solution is aligned precisely with your needs. This helps our experts to deliver the most accurate, latest, and relevant solution.

What is a Case Research Method? How can it be applied to the Dengue - Sustainable Large Scale Vaccine Delivery in Low-Income Markets (A): The Challenges of Vaccine Launches in Emerging Markets case study?

The Case Research Method involves in-depth analysis of a situation, identifying key issues, and proposing strategic solutions. For "Dengue - Sustainable Large Scale Vaccine Delivery in Low-Income Markets (A): The Challenges of Vaccine Launches in Emerging Markets" case study, this method would be applied by examining the case’s context, challenges, and opportunities to provide a robust solution that aligns with academic rigor.

"I’m Seeking Help with Case Studies,” How can Fern Fort University help me with my case study assignments?

Fern Fort University offers comprehensive case study solutions, including writing, analysis, and consulting services. Whether you need help with strategy formulation, problem-solving, or academic compliance, their experts are equipped to assist with your assignments.

Achieve academic excellence with Fern Fort University! 🌟 We offer custom essays, term papers, and Harvard HBR business case studies solutions crafted by top-tier experts. Experience tailored solutions, uncompromised quality, and timely delivery. Elevate your academic performance with our trusted and confidential services. Visit Fern Fort University today! #AcademicSuccess #CustomEssays #MBA #CaseStudies

How do you handle tight deadlines for case study solutions?

We are adept at managing tight deadlines by allocating sufficient resources and prioritizing urgent projects. Our team works efficiently without compromising quality, ensuring that even last-minute requests are delivered on time

What if I need revisions or edits after receiving the case study solution?

We offer free revisions to ensure complete client satisfaction. If any adjustments are needed, our team will work closely with you to refine the solution until it meets your expectations.

How do you ensure that the case study solution is plagiarism-free?

All our case study solutions are crafted from scratch and thoroughly checked using advanced plagiarism detection software. We guarantee 100% originality in every solution delivered

How do you handle references and citations in the case study solutions?

We follow strict academic standards for references and citations, ensuring that all sources are properly credited according to the required citation style (APA, MLA, Chicago, etc.).

Hire an expert to write custom solution for HBR Entrepreneurhsip case study - Dengue - Sustainable Large Scale Vaccine Delivery in Low-Income Markets (A): The Challenges of Vaccine Launches in Emerging Markets



Most Read


Referrences & Bibliography for SWOT Analysis | SWOT Matrix | Strategic Management

1. Andrews, K. R. (1980). The concept of corporate strategy. Harvard Business Review, 61(3), 139-148.

2. Ansoff, H. I. (1957). Strategies for diversification. Harvard Business Review, 35(5), 113-124.

3. Brandenburger, A. M., & Nalebuff, B. J. (1995). The right game: Use game theory to shape strategy. Harvard Business Review, 73(4), 57-71.

4. Christensen, C. M., & Raynor, M. E. (2003). Why hard-nosed executives should care about management theory. Harvard Business Review, 81(9), 66-74.

5. Christensen, C. M., & Raynor, M. E. (2003). The innovator's solution: Creating and sustaining successful growth. Harvard Business Review Press.

6. D'Aveni, R. A. (1994). Hypercompetition: Managing the dynamics of strategic maneuvering. Harvard Business Review Press.

7. Ghemawat, P. (1991). Commitment: The dynamic of strategy. Harvard Business Review, 69(2), 78-91.

8. Ghemawat, P. (2002). Competition and business strategy in historical perspective. Business History Review, 76(1), 37-74.

9. Hamel, G., & Prahalad, C. K. (1990). The core competence of the corporation. Harvard Business Review, 68(3), 79-91.

10. Kaplan, R. S., & Norton, D. P. (1992). The balanced scorecard--measures that drive performance. Harvard Business Review, 70(1), 71-79.

11. Kim, W. C., & Mauborgne, R. (2004). Blue ocean strategy. Harvard Business Review, 82(10), 76-84.

12. Kotter, J. P. (1995). Leading change: Why transformation efforts fail. Harvard Business Review, 73(2), 59-67.

13. Mintzberg, H., Ahlstrand, B., & Lampel, J. (2008). Strategy safari: A guided tour through the wilds of strategic management. Harvard Business Press.

14. Porter, M. E. (1979). How competitive forces shape strategy. Harvard Business Review, 57(2), 137-145.

15. Porter, M. E. (1980). Competitive strategy: Techniques for analyzing industries and competitors. Simon and Schuster.

16. Porter, M. E. (1985). Competitive advantage: Creating and sustaining superior performance. Free Press.

17. Prahalad, C. K., & Hamel, G. (1990). The core competence of the corporation. Harvard Business Review, 68(3), 79-91.

18. Rumelt, R. P. (1979). Evaluation of strategy: Theory and models. Strategic Management Journal, 1(1), 107-126.

19. Rumelt, R. P. (1984). Towards a strategic theory of the firm. Competitive Strategic Management, 556-570.

20. Teece, D. J., Pisano, G., & Shuen, A. (1997). Dynamic capabilities and strategic management. Strategic Management Journal, 18(7), 509-533.